Source: European Journal of Clinical Pharmacology. Unidade: FCF
Subjects: PANDEMIAS, COVID-19, CORONAVIRUS
ABNT
VAZ, Elisa Souza et al. Drug repositioning in the COVID-19 pandemic: fundamentals, synthetic routes, and overview of clinical studies. European Journal of Clinical Pharmacology, v. 79, p. 723–751, 2023Tradução . . Disponível em: https://doi.org/10.1007/s00228-023-03486-4. Acesso em: 19 ago. 2024.APA
Vaz, E. S., Vassiliades, S. V., Giarolla, J., Polli, M. C., & Parise Filho, R. (2023). Drug repositioning in the COVID-19 pandemic: fundamentals, synthetic routes, and overview of clinical studies. European Journal of Clinical Pharmacology, 79, 723–751. doi:10.1007/s00228-023-03486-4NLM
Vaz ES, Vassiliades SV, Giarolla J, Polli MC, Parise Filho R. Drug repositioning in the COVID-19 pandemic: fundamentals, synthetic routes, and overview of clinical studies [Internet]. European Journal of Clinical Pharmacology. 2023 ; 79 723–751.[citado 2024 ago. 19 ] Available from: https://doi.org/10.1007/s00228-023-03486-4Vancouver
Vaz ES, Vassiliades SV, Giarolla J, Polli MC, Parise Filho R. Drug repositioning in the COVID-19 pandemic: fundamentals, synthetic routes, and overview of clinical studies [Internet]. European Journal of Clinical Pharmacology. 2023 ; 79 723–751.[citado 2024 ago. 19 ] Available from: https://doi.org/10.1007/s00228-023-03486-4